Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Nigeria

Nigeria Planning To Manufacture ACTs

April 2006 | Company Finance Alert

Nigeria is planning to begin the local manufacture artemisinin-based combination therapies (ACTs) to combat malaria. Local drugmaker Emzor has recently started producing ACTs, which are the recommended treatment for the disease. This is because monotherapy anti-malarial drugs frequently causes malarial resistance. Nigeria 16mn doses of ACTs have been ordered through the Global

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Kano Sues Pfizer Over Trovan

Companies / Nigeria The State Government of Kano, Nigeria, is suing Pfizer International , the Nigerian subsidiary of Pfizer , the world's largest drugmaker, for a total of US$2.7bn. The lawsuit stems from a controversial...
May 2007
Crusade Against Fake Drugs Gathers Momentum

Companies / Nigeria With BMI believing that Nigeria's drug market remains undervalued considering the size of the population, we examine drug regulator NAFDAC's ongoing efforts in the fight against counterfeit medicines....
April 2007
Tariffs Harming Access To Essential Medicines

Companies / Nigeria According to the World Health Organisation (WHO), two-thirds of the world's population - and 80% of Africans - do not have adequate access to drugs. Yet,
December 2006
Emzor Launches First ACT

Companies / Nigeria Nigerian drugmaker Emzor Pharmaceuticals - which has recently celebrated its 20th year - has launched a new malaria drug. Diasunate is an artemisinin-based combination therapy (ACT). The WHO recommends...
October 2006
Pfizer Comments On Health Sector's Challenges

Companies / Nigeria The Managing Director of Pfizer Nigeria has recently stated that 'organic development' and 'investment in infrastructure' are the keys to improving the African health sector. These twin goals could be...
October 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS